Trinity Biotech (TRIB) Net Income (2009 - 2024)

Trinity Biotech has disclosed Net Income across 16 years of filings, most recently posting -$17.0 million for Q4 2024.

• In Q4 2024, Net Income fell 208.16% year-over-year to -$17.0 million; the TTM figure through Dec 2024 stood at -$22.9 million (down 37.58% YoY), while the FY2025 annual figure was -$37.4 million, down 17.58% from the prior year.
• Net Income came in at -$17.0 million for Q4 2024 at Trinity Biotech, down from -$4.8 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $8.3 million in Q3 2020 to a low of -$17.0 million in Q4 2024.
• Average Net Income over 5 years is -$2.2 million, with a median of -$933500.0 recorded in 2020.
• The largest YoY upside for Net Income was 2441.54% in 2020 against a maximum downside of 810.89% in 2020.
• Over 5 years, Net Income stood at $7.1 million in 2020, then plunged by 151.21% to -$3.6 million in 2021, then sank by 176.77% to -$10.1 million in 2022, then surged by 45.42% to -$5.5 million in 2023, then tumbled by 208.16% to -$17.0 million in 2024.
• Per Business Quant data, the three most recent Net Income figures were -$17.0 million in Q4 2024, -$4.8 million in Q3 2024, and -$1.1 million in Q2 2024.